The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease
Open accessAbstract
OBJECTIVE: To make a quantitative assessment of the relation between disarray, fibrosis, and small vessel disease in hypertrophic cardiomyopathy. DESIGN: Detailed macroscopic and histological examination at 19 segments of the left and right ventricle and the left atrial free wall. PATIENTS: 72 patients with hypertrophic cardiomyopathy who had suffered sudden death or progression to end stage cardiac failure (resulting in death or heart transplantation). MAIN OUTCOME MEASURES: The presence of scarring, atrial dilatation, and a mitral valve impact lesion were noted, and heart weight, wall thickness, per cent disarray, per cent fibrosis, and per cent small vessel disease quantitated for each heart. RESULTS: Within an individual heart the magnitude of hypertrophy correlated with the severity of fibrosis (p = 0.006) and disarray (p = 0.0002). Overall, however, total heart weight related weakly but significantly to fibrosis (r = 0.4, p = 0.0001) and small vessel disease (r = 0.3, p = 0.03), but not to disarray. Disarray was greater in hearts with mild left ventricular hypertrophy (maximum wall thickness < 20 mm) and preserved systolic function (60.9 (26)% v 43 (20.4)% respectively, p = 0.02) and hearts without a mitral valve impact lesion (26.3% v 18.9%, p = 0.04), but was uninfluenced by sex. Fibrosis was influenced by sex (7% in male patients and 4% in female, p = 0.04), but not by the presence of an impact lesion. No relation was found between disarray, fibrosis, and small vessel disease. CONCLUSIONS: Myocyte disarray is probably a direct response to functional or structural abnormalities of the mutated sarcomeric protein, while fibrosis and small vessel disease are secondary phenomena unrelated to disarray, but modified by factors such as left ventricular mass, sex, and perhaps local autocrine factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS
Teare, D. (1958) · Heart · doi:10.1136/hrt.20.1.1 · Cited by 1,081
Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy
Maron, B. J., Wolfson, J. K., Epstein, S. E., & Roberts, W. C. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80181-4 · Cited by 756
A Mouse Model of Familial Hypertrophic Cardiomyopathy
Geisterfer-Lowrance, A. A. T., Christe, M., Conner, D. A., Ingwall, J. S., Schoen, F. J., Seidman, C. E., & Seidman, J. G. (1996) · Science · doi:10.1126/science.272.5262.731 · Cited by 556
Tanaka, M., Fujiwara, H., Onodera, T., Wu, D. J., Matsuda, M., Hamashima, Y., & Kawai, C. (1987) · Circulation · doi:10.1161/01.cir.75.6.1130 · Cited by 309
Recent Advances in the Molecular Genetics of Hypertrophic Cardiomyopathy
Marian, A. J., & Roberts, R. (1995) · Circulation · doi:10.1161/01.cir.92.5.1336 · Cited by 209
Molecular Basis of Familial Cardiomyopathies
Schwartz, K., Carrier, L., Guicheney, P., & Komajda, M. (1995) · Circulation · doi:10.1161/01.cir.91.2.532 · Cited by 179
St John Sutton, M. G., Lie, J. T., Anderson, K. R., O'Brien, P. C., & Frye, R. L. (1980) · Heart · doi:10.1136/hrt.44.4.433 · Cited by 177
The current status of myocardial disarray in hypertrophic cardiomyopathy.
Davies, M. J. (1984) · Heart · doi:10.1136/hrt.51.4.361 · Cited by 101
Maron, B. J., Wolfson, J. K., & Roberts, W. C. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90560-l · Cited by 82
Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass.
Maron, B. J., Kragel, A. H., & Roberts, W. C. (1990) · Heart · doi:10.1136/hrt.63.5.308 · Cited by 78
Cited by
Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies
Mahrholdt, H., Wagner, A., Judd, R. M., Sechtem, U., & Kim, R. J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi258 · Cited by 914
Moon, J. C. C., McKenna, W. J., McCrohon, J. A., Elliott, P. M., Smith, G. C., & Pennell, D. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00189-x · Cited by 766
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Ho, C. Y., López, B., Coelho-Filho, O. R., Lakdawala, N. K., Cirino, A. L., Jarolim, P., Kwong, R., González, A., Colan, S. D., Seidman, J. G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002659 · Cited by 696
Elliott, P., & McKenna, W. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16358-7 · Cited by 498
Rubinshtein, R., Glockner, J. F., Ommen, S. R., Araoz, P. A., Ackerman, M. J., Sorajja, P., Bos, J. M., Tajik, A. J., Valeti, U. S., Nishimura, R. A., et al. (2010) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.854026 · Cited by 418
Metadata
- Authors
- Varnava, A. M.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2000-11-01
- Volume
- 84
- Issue
- 5
- Pages
- 476-482
- ISSN
- 1355-6037 (ISSN-L)
- 0007-0769
- OpenAlex
- W2160789215
- Cited by
- 441
- References
- 12
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. https://app.cochat.ai/papers/10.1136/heart.84.5.476
- The paper
- Varnava, A. M. (2000). Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart. https://doi.org/10.1136/heart.84.5.476
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.